SynGenis is VC-Backed and has raised funding across Venture - General / Other and Venture - General / Other rounds. It is backed by Perron Institute for Neurological and Translational Science and Mondo Electronics.
Alternatives.pe tracks SynGenis's funding history, valuation trends, ownership structure, and transaction activity over time.
Last Updated: 2026-07-21
Explore the latest updates and insights
SynGenis has completed an oversubscribed AUD 4 million pre-float capital raising.
New Industries Fund: Commercialisation Bridge Grant 2024 recipients
Manufacturing boost for SynGenis through Government Funding
SpeeDx and SynGenis Partner for Custom Oligonucleotide Synthesis
A view of the number of employees over time
Key members of the management team